Disclosing pathogenic processes of monkeypox (MPOX) and drug repurposing through host-transcriptomics analysis. (PubMed, PLoS Negl Trop Dis) - Oct 17, 2026 - "Based on molecular docking analysis, five top-ranked drug molecules Tecovirimat, Beclabuvir, Maraviroc, Raltegravir, and Brincidofovir were identified as potential repurposable therapeutics against MPOX. Therefore, the results provided in this study might be potential resources for diagnosis and therapies of MPOX patients. However, the findings require experimental validation in wet lab for further confirmation."
Journal • Infectious Disease • ABL1 • CDC37 • CDH1 • HSP90AA1 • IGF1 • PPARG • PTPRC
|
|
Alvira Ajadee; Md Ahad Ali; Md Fahim Faysal; Md Feroj Ahmed; Md Hadiul Kabir; Md Masud Rana; Md Nurul Haque Mollah; Reaz Ahmmed; Sabkat Mahmud; Tasfia Noor
|